ENTITY
Kelun Biotech

Kelun Biotech (1885133D CH)

26
Analysis
Health CareChina
Kelun Biotech operates biotechnology businesses. The Company develops and provides biological drugs, chemical raw materials, chemical preparations, and other products. Kelun Biotech also operates import and export businesses.
more
Refresh
bearishWuXi XDC Cayman
17 Aug 2023 10:31

WuXi XDC Cayman Pre-IPO - The Negatives - Bottlenecks Have Held Margins Back. Receivables Ballooning

WuXi XDC Cayman Inc (1877628D HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. In this note, we will talk about the not-so...

Logo
533 Views
Share
bullishWuXi XDC Cayman
16 Aug 2023 11:01

WuXi XDC Cayman Pre-IPO - The Positives - Sales Have Surged Leading to Market Share Gains

WuXi XDC Cayman Inc (1877628D HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. In this note, we will talk about the positive...

Logo
445 Views
Share
16 Jul 2023 08:08

ECM Weekly (16th July 2023) - LG Energy, Socionext, Plus Alpha, Syngenta, Cinema XXI, Genda, Fadu

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
399 Views
Share
bullishKelun Biotech
12 Jul 2023 09:25

Pre-IPO Kelun Biotech (PHIP Updates) - Some Points Worth the Attention

Currently, Kelun-Biotech's market value has already been higher than that of Keymed. Considering Keymed has complete R&D team within the company,...

Logo
584 Views
Share
bullishKelun Biotech
10 Jul 2023 15:03

Kelun-Biotech (科伦博泰) IPO Trading: Lukewarm Demand but Peers Have Done Well Recently

Kelun Biotech will start trading on July 11th. We provide an update of the IPO before its debut. We think the deal attracted lukewarm demand but...

Logo
388 Views
Share
x